This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Bell, R. D. Articles by Albin, M. S. Search for Related Content PubMed PubMed Citation Articles by Bell, R. D. Articles by Albin, M. S.

Stroke, Vol 17, 254-260, Copyright © 1986 by American Heart Association

ARTICLES

Quantification of cerebral infarct size by creatine kinase BB isoenzyme

RD Bell, GM Alexander, T Nguyen and MS Albin

Creatine Kinase BB isoenzyme (CKBB) has been shown to rise in the serum and CSF following acute cerebral injury. To test the hypothesis that brain infarct size could be estimated from the appearance and disappearance of CKBB in the serum and CSF, strokes of varying size were produced in twelve mongrel dogs by silastic emboli. The rate of disappearance, Kd of CKBB (-.00732 +/- 0.001 min-1 mean +/- SE, N = 8) was determined by injecting purified CKBB (25 IU) intravenously then measuring its disappearance. Following the embolic stroke, serum samples were taken hourly for 24 hours and then at intervals for up to 160 hours for measurement of CKBB by radioimmunoassay until the animals were sacrificed. The brains were then removed, fixed in formalin, cut in 2 mm sections and photographed. The area of the infarct was measured using high pad digitizer interfaced with an Apple computer. The infarct size was then calculated from the area and thickness. Using a one- compartment mathematical model, the infarct size was estimated from the amount of CKBB appearing in the serum, the Kd of CKBB, and the amount of CKBB depleted from tissue. The computed infarct size correlated well (r = 0.94) with the measured infarct size. This model may have value in testing therapeutic modalities in the intact animal.

This article has been cited by other articles:

				R. D. Bell and M. Khan Cerebrospinal Fluid Creatine Kinase-BB Activity: A Perspective Arch Neurol, November 1, 1999; 56(11): 1327 - 1328. [Full Text] [PDF]

				W. M. Coplin, W. T. Longstreth Jr, A. M. Lam, W. L. Chandler, T. S. Mayberg, J. S. Fine, and H. R. Winn Cerebrospinal Fluid Creatine Kinase-BB Isoenzyme Activity and Outcome After Subarachnoid Hemorrhage Arch Neurol, November 1, 1999; 56(11): 1348 - 1352. [Abstract] [Full Text] [PDF]

				R. O. Roine, H. Somer, M. Kaste, L. Viinikka, and S.-L. Karonen Neurological Outcome After Out-of-Hospital Cardiac Arrest: Prediction by Cerebrospinal Fluid Enzyme Analysis Arch Neurol, July 1, 1989; 46(7): 753 - 756. [Abstract] [PDF]